These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 29702079)

  • 1. The ubiquitin proteasome system as a potential therapeutic target for systemic sclerosis.
    Meiners S; Evankovich J; Mallampalli RK
    Transl Res; 2018 Aug; 198():17-28. PubMed ID: 29702079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets.
    Gabrielli A; Svegliati S; Moroncini G; Luchetti M; Tonnini C; Avvedimento EV
    Autoimmun Rev; 2007 Dec; 7(2):121-6. PubMed ID: 18035321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More Than Just Cleaning: Ubiquitin-Mediated Proteolysis in Fungal Pathogenesis.
    Cao C; Xue C
    Front Cell Infect Microbiol; 2021; 11():774613. PubMed ID: 34858882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the ubiquitin proteasome system in haematological malignancies.
    Crawford LJ; Irvine AE
    Blood Rev; 2013 Nov; 27(6):297-304. PubMed ID: 24183816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course.
    Becker MO; Riemekasten G
    Expert Rev Clin Immunol; 2016; 12(2):115-35. PubMed ID: 26558747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the ubiquitin-proteasome system in heart disease: the basis for new therapeutic strategies.
    Drews O; Taegtmeyer H
    Antioxid Redox Signal; 2014 Dec; 21(17):2322-43. PubMed ID: 25133688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysfunction of constitutive and inducible ubiquitin-proteasome system in amyotrophic lateral sclerosis: implication for protein aggregation and immune response.
    Bendotti C; Marino M; Cheroni C; Fontana E; Crippa V; Poletti A; De Biasi S
    Prog Neurobiol; 2012 May; 97(2):101-26. PubMed ID: 22033150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early inflammatory players in cutanous fibrosis.
    Raker V; Haub J; Stojanovic A; Cerwenka A; Schuppan D; Steinbrink K
    J Dermatol Sci; 2017 Sep; 87(3):228-235. PubMed ID: 28655471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ubiquitin-Proteasome System in Immune Cells.
    Çetin G; Klafack S; Studencka-Turski M; Krüger E; Ebstein F
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33466553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ubiquitin proteasome system as a potential target for the treatment of neurodegenerative diseases.
    Ying Z; Wang H; Wang G
    Curr Pharm Des; 2013; 19(18):3305-14. PubMed ID: 23151138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Tale of Two Proteolytic Machines: Matrix Metalloproteinases and the Ubiquitin-Proteasome System in Pulmonary Fibrosis.
    Roque W; Boni A; Martinez-Manzano J; Romero F
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll Like Receptors in systemic sclerosis: An emerging target.
    O'Reilly S
    Immunol Lett; 2018 Mar; 195():2-8. PubMed ID: 28888416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulating the Ubiquitin-Proteasome System: A Therapeutic Strategy for Autoimmune Diseases.
    Yadav D; Lee JY; Puranik N; Chauhan PS; Chavda V; Jin JO; Lee PCW
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitin-proteasome system and hereditary cardiomyopathies.
    Schlossarek S; Frey N; Carrier L
    J Mol Cell Cardiol; 2014 Jun; 71():25-31. PubMed ID: 24380728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Plant Immunity by the Proteasome.
    Copeland C; Li X
    Int Rev Cell Mol Biol; 2019; 343():37-63. PubMed ID: 30712674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin-proteasome system in diabetic retinopathy.
    Svikle Z; Peterfelde B; Sjakste N; Baumane K; Verkauskiene R; Jeng CJ; Sokolovska J
    PeerJ; 2022; 10():e13715. PubMed ID: 35873915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmunity in scleroderma: the origin, pathogenetic role, and clinical significance of autoantibodies.
    Harris ML; Rosen A
    Curr Opin Rheumatol; 2003 Nov; 15(6):778-84. PubMed ID: 14569210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of primary cilia formation by the ubiquitin-proteasome system.
    Shearer RF; Saunders DN
    Biochem Soc Trans; 2016 Oct; 44(5):1265-1271. PubMed ID: 27911708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging role of the ubiquitin proteasome in pulmonary biology and disease.
    Weathington NM; Sznajder JI; Mallampalli RK
    Am J Respir Crit Care Med; 2013 Sep; 188(5):530-7. PubMed ID: 23713962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ubiquitin-proteasome system and cardiovascular disease.
    Powell SR; Herrmann J; Lerman A; Patterson C; Wang X
    Prog Mol Biol Transl Sci; 2012; 109():295-346. PubMed ID: 22727426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.